After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Celgene posted second-quarter earnings which exceeded analyst consensus expectations by a small margin but enough to raise guidance for the remainder of the year.
Celgene (CELG) stock is trading higher pre-market after reporting its 2016 second quarter financial results.
TheStreet highlights 3 stocks pushing the health care sector lower today.
When your top line declines, it's harder to convince investors it's okay to wait years see if a partnership in an early-stage biotech company delivers a home-run drug.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.